ArticlePloS one2022
Scheduling mechanisms to control the spread of COVID-19.
Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We study scheduling mechanisms that explore the trade-off between containing the spread of COVID-19 and performing in-person activity in organizations. Our mechanisms, referred to as group scheduling, are based on partitioning the population randomly into groups and scheduling each group on appropriate days with possible gaps (when no one is working and all are quarantined). Each group interacts with no other group and, importantly, any person who is symptomatic in a group is quarantined. We show that our mechanisms effectively trade-off in-person activity for more effective control of the COVID-19 virus spread. In particular, we show that a mechanism which partitions the population into two groups that alternatively work in-person for five days each, flatlines the number of COVID-19 cases quite effectively, while still maintaining in-person activity at 70% of pre-COVID-19 level. Other mechanisms that partitions into two groups with less continuous work days or more spacing or three groups achieve even more aggressive control of the virus at the cost of a somewhat lower in-person activity (about 50%). We demonstrate the efficacy of our mechanisms by theoretical analysis and extensive experimental simulations on various epidemiological models based on real-world data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.